RESUMO
The results of a clinical outcome study (N = 57) comparing behavior therapy directed at panic disorder (panic control treatment [PCT]) with alprazolam were reported. These conditions were compared with a medication placebo and a waiting-list control group. Patterns of results on measures of panic attacks, generalized anxiety, and global clinical ratings reveal that PCT was significantly more effective than placebo and waiting-list conditions on most measures. The alprazolam group differed significantly from neither PCT nor placebo. The percentage of clients completing the study who were free of panic attacks following PCT was 87%, compared with 50% for alprazolam, 36% for placebo, and 33% for the waiting-list group. Since alprazolam may work more quickly than PCT but may also interfere with the effects of behavioral treatment, these data suggest a series of studies on the feasibility of integrating these treatments and on the precise patterns and mechanisms of action of various successful treatment approaches to panic disorder.
RESUMO
The results of a clinical outcome study (N = 57) comparing behavior therapy directed at panic disorder (panic control treatment [PCT]) with alprazolam were reported. These conditions were compared with a medication placebo and a waiting-list control group. Patterns of results on measures of panic attacks, generalized anxiety, and global clinical ratings reveal that PCT was significantly more effective than placebo and waiting-list conditions on most measures. The alprazolam group differed significantly from neither PCT nor placebo. The percentage of clients completing the study who were free of panic attacks following PCT was 87%, compared with 50% for alprazolam, 36% for placebo, and 33% for the waiting-list group. Since alprazolam may work more quickly than PCT but may also interfere with the effects of behavioral treatment, these data suggest a series of studies on the feasibility of integrating these treatments and on the precise patterns and mechanisms of action of various successful treatment approaches to panic disorder.
Assuntos
Alprazolam/uso terapêutico , Transtornos de Ansiedade/tratamento farmacológico , Terapia Comportamental , Medo/efeitos dos fármacos , Adolescente , Adulto , Idoso , Alprazolam/farmacologia , Análise de Variância , Transtornos de Ansiedade/diagnóstico , Distribuição de Qui-Quadrado , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pacientes Desistentes do TratamentoRESUMO
The American Cancer Society (ACS) recommends annual screening mammography for asymptomatic women over 50 years old. In a survey of attitudes and referral practices toward screening mammography, one-fifth (886) of the 4200 physicians queried returned a postage-paid questionnaire. Only 11% of respondents followed the ACS guidelines. Physicians under 40 years old, in group practice, or in surgical specialties were more apt to refer their patients for screening. The major deterrent to referral was the perceived high cost and low yield of screening. However, 80% of the physicians indicated they would refer patients over 50 who requested annual screening. Annual mammography screening is underused; greater efforts must be directed toward educating physicians and patients regarding its value and toward lowering its cost.
